Symbols

Symbols

EVO

EVO

Evotec SE Reports Q3 Revenues Down 7.1% to €535.1m, D&PD Revenues Down 12.3% to €392.1m

Tuesday Nov 04, 2025

Evotec Sells Just-Evotec Biologics Site to Sandoz AG for Unspecified Terms.

Evotec shares surge 14.36% after-hours after signing $650M+ deal with Sandoz for Toulouse site sale and continuous manufacturing technology licensing.

Evotec shares surge 21.16% after-hours after signing $650M+ deal with Sandoz for asset-light transition.

Wednesday Oct 29, 2025

Evotec SE to Announce Q3 2025 Results on November 5, 2025

Tuesday Oct 28, 2025

Evaluating Evotec's Valuation After Recent Share Price Surge: Undervalued or Optimistic?

Tuesday Sep 16, 2025

Evotec SE shares fall 1.08% after-hours as a member of the managing body acquires shares.

Thursday Sep 11, 2025

Evotec shares rise 2.05% intraday after Kazia Therapeutics announced new findings from a collaborative research program.

Tuesday Sep 09, 2025

Undervalued Biotech: Evotec's 29.5% Price Drop Creates Opportunity for Long-Term Growth

Friday Sep 05, 2025

Evotec shares rise 2.67% premarket after being replaced by Fielmann in the MDAX.

Thursday Sep 04, 2025

Evotec shares fall 1.45% premarket after RBC retains outperform rating.

Friday Aug 15, 2025

HC Wainwright Maintains Buy Rating on Evotec, Lowers Price Target to $7.00

Evotec AG Reports Q1 2025 Results, Plans Sale of Biologics Segment to Sandoz AG

Evotec's Price Target Lowered to $7, Analyst Says Biotech Funding Softness to Hurt Revenue

Thursday Aug 14, 2025

Evotec: HC Wainwright & Co. Maintains Buy Rating, PT Down to $7

Wednesday Aug 13, 2025

Evotec shares fall 1.57% premarket after reporting H1 2025 results with mixed revenue performance.

Evotec shares rise 2.36% premarket after reporting strong H1 2025 results and progress in collaborations with Bristol Myers Squibb.

Evotec Reports H1 2025 Results: Strategy for Sustainable Growth Progressing Ahead of Plan

Tuesday Aug 12, 2025

Evotec Earnings Release: Analysts Predict $-0.12 EPS

Evotec SE Q2 2025 Earnings Preview: Revenue Expected to Reach $237.53 Million